Placenta & Pregnancy Disorders

(A/Prof Chan Shiao-yng)

placenta and pregnancy disorders

Our research covers the spectrum from basic laboratory science to translational sciences and clinical trials. Our main focus is understanding the normal development of the placenta and fetus, and investigating the impact of different environmental and maternal medical conditions. More specifically, we study the cellular mechanisms of endocrine action in fetal-placental growth and development, diagnosis and management of diabetes and thyroid disorders in pregnancy, transplacental passage of hormones, nutrients and lipids, and conduct clinical trials starting preconception or in early pregnancy. For example, we are one of three international centres conducting the NiPPeR clinical trial that investigates the efficacy of a special nutritional formulation containing myo-inositol, probiotics and additional micronutrients in improving glucose metabolism during pregnancy, as well as pregnancy and child outcomes. Such trials offer the prospect of new strategies in optimising maternal health before pregnancy in order to promote healthy fetal development. Meanwhile, our laboratory research provides complimentary information alongside on-going clinical trials to help us better understand underlying mechanisms as well as generate new knowledge that enables development of further improved interventions. We also run other projects investigating the impact of mosquito-borne viral infections such as the Zika virus, the role of ambient temperatures and implications of maternal mood and stress on pregnancy and child outcomes.

In the area of placental physiology, we are now studying conditions with high incidences in Singapore, such as insulin resistance and gestational diabetes. In collaboration with Singapore Lipidomics Incubator (NUS), we have advanced our understanding in the area of placental lipid flux, using state-of-the-art lipidomic mass spectrometry techniques. We are starting to make remarkable discoveries of how placental lipid metabolism and flux may impact fetal growth and development. Our group has developed close collaboration with researchers within NUS, and across Singapore as well as collaborate with eminent researchers abroad (UK, New Zealand, Australia), and with industry partners.

Overall, our research seeks to develop and validate novel interventions and health advice to optimize maternal health status to improve pregnancy outcomes and reduce future offspring health risks. Better understanding of the placenta, optimising care of women before and during pregnancy will ultimately improve the health of the next and subsequent generations.

Publications

  1. Anne HY Chu, Izzuddin M Aris, Sharon Ng, See Ling Loy, Jonathan Y Bernard, Mya Thway Tint1,2, Wen Lun Yuan7, Keith M Godfrey8, Jerry Kok Yen Chan4,5, Lynette Pei-Chi Shek1,7, Yap Seng Chong1,2, Kok Hian Tan5,9, Seng Bin Ang10, Heng Hao Tan4,5, Bernard SM Chern5,11, Fabian Yap12,13, Yung Seng Lee1,7, Ngee Lek5,13, Melvin Khee-Shing Leow, Chin Meng Khoo, Shiao-yng Chan. Scientific Reports (in press). Anthropometric measures and HbA1c to detect dysglycemia in young Asian women planning conception: The S-PRESTO cohort.
  2. Chu AHY, Tint MT, Chang HF, Wong G, Yuan WL, Tull D, Nijagal B, Narayana VK, Meikle PJ, Chang KTE, Lewis RM, Chi C, Yap FKP, Tan KH, Shek LP, Chong YS, Gluckman PD, Lee YS, Fortier MV, Godfrey KM, Eriksson JG, Karnani N, Chan SY.Chu AHY, et al. Int J Obes (Lond). 2020 May 20. doi: 10.1038/s41366-020-0596-5. High placental inositol content associated with suppressed pro-adipogenic effects of maternal glycaemia in offspring: the GUSTO cohort.
  3. Watkins OC, Islam MO, Selvam P, Pillai RA, Cazenave-Gassiot A, Bendt AK, Karnani N, Godfrey KM, Lewis RM, Wenk MR, Chan SY.Watkins OC, et al. J Endocrinol. 2019 Aug 1:JOE-19-0267.R1. 234(1):73-84 doi: 10.1530/JOE-19-0267. Myo-inositol alters 13C-labeled fatty acid metabolism in human placental explants.
  4. Watkins OC, Islam MO, Selvam P, Pillai RA, Cazenave-Gassiot A, Bendt AK, Karnani N, Godfrey KM, Lewis RM, Wenk MR, Chan SY.Watkins OC, et al. Endocrinology. 2019 Jun 1;160(6):1394-1408. doi: 10.1210/en.2018-01020. Metabolism of 13C-Labeled Fatty Acids in Term Human Placental Explants by Liquid Chromatography-Mass Spectrometry.
  5. Dhillon-Smith RK, Middleton LJ, Sunner KK, Cheed V, Baker K, Farrell-Carver S, Bender-Atik R, Agrawal R, Bhatia K, Edi-Osagie E, Ghobara T, Gupta P, Jurkovic D, Khalaf Y, MacLean M, McCabe C, Mulbagal K, Nunes N, Overton C, Quenby S, Rai R, Raine-Fenning N, Robinson L, Ross J, Sizer A, Small R, Tan A, Underwood M, Kilby MD, Boelaert K, Daniels J, Thangaratinam S, Chan SY, Coomarasamy A. N Engl J Med. 2019 Apr 4;380(14):1316-1325. doi: 10.1056/NEJMoa1812537. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception.
  • Home
  • Research
  • Reproductive & Developmental Biology Research Programme
  • Placenta & Pregnancy Disorders